Stablepoint Partners’s GSK GSK Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $4.73M | Buy |
123,294
+2,498
| +2% | +$95.9K | 0.81% | 45 |
|
|
2025
Q1 | $4.68M | Buy |
120,796
+21,232
| +21% | +$823K | 0.85% | 43 |
|
|
2024
Q4 | $3.37M | Sell |
99,564
-4,840
| -5% | -$164K | 0.62% | 57 |
|
|
2024
Q3 | $4.27M | Buy |
104,404
+135
| +0.1% | +$5.52K | 0.78% | 50 |
|
|
2024
Q2 | $4.17M | Buy |
104,269
+4
| +0% | +$160 | 0.81% | 48 |
|
|
2024
Q1 | $4.47M | Buy |
104,265
+6,375
| +7% | +$273K | 0.91% | 41 |
|
|
2023
Q4 | $3.63M | Buy |
+97,890
| New | +$3.63M | 0.93% | 44 |
|